ONCOLOGY, NUCLEAR MEDICINE AND TRANSPLANTOLOGY
Abstract
Oct 03, 2025 1 0

Prognostic Significance of CD56 Expression in AML in Pediatric and Adult Populations

R. A. Aliyeva 1 * ,
A. A. Kerimov 1 * ,
N. V. Ismail 1
1 National Center of Hematology and Transfusion, Baku, Azerbaijan* Corresponding Author
Oncology, Nuclear Medicine and Transplantology, 1(Suppl. 1), 2025, onmt_A16
Publication date: Oct 03, 2025
Full Text (PDF)

ABSTRACT

---

KEYWORDS

---

CITATION (Vancouver)

Aliyeva RA, Kerimov AA, Ismail NV. Prognostic Significance of CD56 Expression in AML in Pediatric and Adult Populations. Oncology, Nuclear Medicine and Transplantology. 2025;1(Suppl. 1):onmt_A16.
APA
Aliyeva, R. A., Kerimov, A. A., & Ismail, N. V. (2025). Prognostic Significance of CD56 Expression in AML in Pediatric and Adult Populations. Oncology, Nuclear Medicine and Transplantology, 1(Suppl. 1), onmt_A16.
Harvard
Aliyeva, R. A., Kerimov, A. A., and Ismail, N. V. (2025). Prognostic Significance of CD56 Expression in AML in Pediatric and Adult Populations. Oncology, Nuclear Medicine and Transplantology, 1(Suppl. 1), onmt_A16.
AMA
Aliyeva RA, Kerimov AA, Ismail NV. Prognostic Significance of CD56 Expression in AML in Pediatric and Adult Populations. Oncology, Nuclear Medicine and Transplantology. 2025;1(Suppl. 1), onmt_A16.
Chicago
Aliyeva, R. A., A. A. Kerimov, and N. V. Ismail. "Prognostic Significance of CD56 Expression in AML in Pediatric and Adult Populations". Oncology, Nuclear Medicine and Transplantology 2025 1 no. Suppl. 1 (2025): onmt_A16.
MLA
Aliyeva, R. A. et al. "Prognostic Significance of CD56 Expression in AML in Pediatric and Adult Populations". Oncology, Nuclear Medicine and Transplantology, vol. 1, no. Suppl. 1, 2025, onmt_A16.

REFERENCES

---

LICENSE

Creative Commons License
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.